Recently, genome-wide searches for multiple sclerosis (MS) susceptibility genes have suggested that the chromosome 17q22-q24 region might contain susceptibility genes in two sets of families of different ethnic backgrounds (Finnish and British). Therefore, we decided to test this region in two sets of families of different ethnic backgrounds (American and French), but collected according to the same diagnostic criteria. All lod-score values were non-significant. Moreover, we could exclude that the 17q22-24 region might contain a gene increasing the sibling recurrence risk of MS over 1.4, rendering the existence of such a gene very unlikely, at least in the group of tested families.
Both candidate gene and genome-wide searches have been performed to identify susceptibility genes to multiple sclerosis. Recently, genome-wide searches for MS susceptibility genes have suggested that the chromosome 17q22-q24 region might contain susceptibility genes in two sets of families of different ethnic backgrounds (Finnish and British). 1, 2 In the British study (227 families), the region on chromosome 17q22 finally yielded to a MLS = 2.7 with a = 1.7. 1 In the Finnish study, 2 positive values were obtained for markers on chromosome 17q22-24 in a genome-wide search on 16 multiplex families using a multipoint, non-parametric linkage analysis (NPL = 2.34). These two findings, although not significant individually, taken together suggest the presence of a risk factor in the 17q22-24 region. Therefore, we decided to re-evaluate this region in two sets of families of different ethnic backgrounds (American and French), but collected according to the same criteria. 3 The characteristics of the family sets are shown in Table 1 : 88 sibpairs of French descent and 114 American sibpairs were studied, ie a total of 202 sibpairs. Five markers regularly spanning the chromosome 17q22-24 region were used: the name of the markers as well as their genetic distances are indicated in Table 2 . DNA genotyping was performed from DNA extracted from whole blood using standard procedures using fluorescent-based detec- tion systems as described. 4 Linkage was tested for each marker using the Maximum Likelihood Approach (MLS). 5 For a sample of affected sibpairs, the MLS estimate was assessed by the Mapmaker/Sibs program. Allele frequencies were estimated from the available parental genotypes.
The genetic information content extracted from MS families was over 80%. All MLS values were non-significant (Table 2 ). For a given risk factor, a parameter is defined as the increase of risk due to this factor for a sib of an affected individual. 6 The presence of a risk factor with an associated greater than a given value * is excluded in areas of the genome where the ratio of the likelihood of = * to the likelihood of = 1 (absence of risk factor) is below −2.
5 For such a threshold, greater than or equal to 1.6, 1.8 and 1.4 were excluded in French, American and all MS families, respectively (denoted as exclusion relative risks in Table 2 ). In fact, this threshold Identifying genes in multigenic disorders such as MS is a difficult task: two genome-wide searches of MS susceptibility genes have indeed concluded to the absence of susceptibility genes with major effect. 1, 7 Our sets of families, although of different ethnic origins, were collected with the same conservative diagnostic criteria. The fact that we could not replicate the suggestive linkage of chromosome 17q22-q24 to MS in Finnish and British families suggests a false-positivity of the former studies. In addition, the British study yielded to an estimated = 1.7. Such a value is excluded in our study. An alternative hypothesis would be a genetic heterogeneity due to the different ethnic backgrounds of the tested samples. The absence of susceptibility factors with major effect and the possible existence of a genetic heterogeneity in MS might increase the difficulty to identify susceptibility genes in MS.
